{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:24:51Z","timestamp":1793049891414,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:00:00Z","timestamp":1587427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:00:00Z","timestamp":1587427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1038\/s41587-020-0512-5","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T22:05:48Z","timestamp":1587506748000},"page":"540-545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":165,"title":["Developing therapeutic monoclonal antibodies at pandemic pace"],"prefix":"10.1038","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1205-1804","authenticated-orcid":false,"given":"Brian","family":"Kelley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,21]]},"reference":[{"key":"512_CR1","doi-asserted-by":"publisher","first-page":"12123","DOI":"10.1073\/pnas.0701000104","volume":"104","author":"Z Zhu","year":"2007","unstructured":"Zhu, Z. et al. Proc. Natl Acad. Sci. USA 104, 12123\u201312128 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"512_CR2","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1205669","volume":"333","author":"D Corti","year":"2011","unstructured":"Corti, D. et al. Science 333, 850\u2013856 (2011).","journal-title":"Science"},{"key":"512_CR3","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.aaf8505","volume":"353","author":"K Stettler","year":"2016","unstructured":"Stettler, K. et al. Science 353, 823\u2013826 (2016).","journal-title":"Science"},{"key":"512_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","volume":"27","author":"R-M Lu","year":"2020","unstructured":"Lu, R.-M. et al. J. Biomed. Sci. 27, 1\u201330 (2020).","journal-title":"J. Biomed. Sci."},{"key":"512_CR5","unstructured":"The Antibody Society. Antibody therapeutics approved or in regulatory review in the EU or US. https:\/\/www.antibodysociety.org\/resources\/approved-antibodies\/ (2020)."},{"key":"512_CR6","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1002\/btpr.2495","volume":"33","author":"Y Rajendra","year":"2017","unstructured":"Rajendra, Y. et al. Biotechnol. Prog. 33, 1436\u20131448 (2017).","journal-title":"Biotechnol. Prog."},{"key":"512_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.coche.2018.09.011","volume":"22","author":"NK Hamaker","year":"2018","unstructured":"Hamaker, N. K. & Lee, K. H. Curr. Opin. Chem. Eng. 22, 152\u2013160 (2018).","journal-title":"Curr. Opin. Chem. Eng."},{"key":"512_CR8","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/btpr.2561","volume":"34","author":"D Shaw","year":"2018","unstructured":"Shaw, D. et al. Biotechnol. Prog. 34, 584\u2013592 (2018).","journal-title":"Biotechnol. Prog."},{"key":"512_CR9","doi-asserted-by":"publisher","first-page":"438","DOI":"10.5731\/pdajpst.2018.008789","volume":"72","author":"K Zingaro","year":"2018","unstructured":"Zingaro, K. et al. PDA J. Pharm. Sci. Technol. 72, 438\u2013450 (2018).","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"512_CR10","doi-asserted-by":"publisher","first-page":"1700766","DOI":"10.1002\/biot.201700766","volume":"14","author":"V Sandner","year":"2019","unstructured":"Sandner, V., Pybus, L. P., McCreath, G. & Glassey, J. Biotechnol. J. 14, 1700766 (2019).","journal-title":"Biotechnol. J."},{"key":"512_CR11","doi-asserted-by":"crossref","unstructured":"Guti\u00e9rrez-Granados, S., Cervera, L., Kamen, A. A. & G\u00f2dia, F. Crit. Rev. Biotechnol. 38, 918\u2013940 (2018).","DOI":"10.1080\/07388551.2017.1419459"},{"key":"512_CR12","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/bit.21904","volume":"100","author":"JL Coffman","year":"2008","unstructured":"Coffman, J. L., Kramarczyk, J. F. & Kelley, B. D. Biotechnol. Bioeng. 100, 605\u2013618 (2008).","journal-title":"Biotechnol. Bioeng."},{"key":"512_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/bit.21923","volume":"101","author":"BD Kelley","year":"2008","unstructured":"Kelley, B. D. et al. Biotechnol. Bioeng. 101, 553\u2013566 (2008).","journal-title":"Biotechnol. Bioeng."},{"key":"512_CR14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.4161\/mabs.1.5.9448","volume":"1","author":"B Kelley","year":"2009","unstructured":"Kelley, B. MAbs 1, 443\u2013452 (2009).","journal-title":"MAbs"},{"key":"512_CR15","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/btpr.2467","volume":"33","author":"Z Hu","year":"2017","unstructured":"Hu, Z. et al. Biotechnol. Prog. 33, 1449\u20131455 (2017).","journal-title":"Biotechnol. Prog."},{"key":"512_CR16","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1002\/btpr.2572","volume":"33","author":"TP Munro","year":"2017","unstructured":"Munro, T. P. et al. Biotechnol. Prog. 33, 1476\u20131482 (2017).","journal-title":"Biotechnol. Prog."},{"key":"512_CR17","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1002\/btpr.2477","volume":"33","author":"L Fan","year":"2017","unstructured":"Fan, L. et al. Biotechnol. Prog. 33, 1456\u20131462 (2017).","journal-title":"Biotechnol. Prog."},{"key":"512_CR18","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/btpr.2548","volume":"33","author":"C Wright","year":"2017","unstructured":"Wright, C., Alves, C., Kshirsagar, R., Pieracci, J. & Estes, S. Biotechnol. Prog. 33, 1468\u20131475 (2017).","journal-title":"Biotechnol. Prog."},{"key":"512_CR19","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/btpr.2493","volume":"33","author":"JJ Scarcelli","year":"2017","unstructured":"Scarcelli, J. J., Shang, T. Q., Iskra, T., Allen, M. J. & Zhang, L. Biotechnol. Prog. 33, 1463\u20131467 (2017).","journal-title":"Biotechnol. Prog."},{"key":"512_CR20","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.xphs.2018.11.042","volume":"108","author":"J Kretsinger","year":"2019","unstructured":"Kretsinger, J. et al. J. Pharm. Sci. 108, 1442\u20131452 (2019).","journal-title":"J. Pharm. Sci."},{"key":"512_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/btpr.1820","volume":"30","author":"J Stuckey","year":"2014","unstructured":"Stuckey, J. et al. Biotechnol. Prog. 30, 79\u201385 (2014).","journal-title":"Biotechnol. Prog."},{"key":"512_CR22","unstructured":"U. S. Food and Drug Administration. Emergency use authorization of medical products and related authorities. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/emergency-use-authorization-medical-products-and-related-authorities (2017)."},{"key":"512_CR23","unstructured":"Yang, W. C. et al. Perfusion seed cultures improve biopharmaceutical fed-batch production capacity and product quality. Biotechnol. Prog. 30, 616\u2013625 (2014)."},{"key":"512_CR24","first-page":"995","volume":"23","author":"B Kelley","year":"2007","unstructured":"Kelley, B. Biotechnol. Prog. 23, 995\u20131008 (2007).","journal-title":"Biotechnol. Prog."},{"key":"512_CR25","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/nbt0506-503","volume":"24","author":"ME Kamarck","year":"2006","unstructured":"Kamarck, M. E. Nat. Biotechnol. 24, 503\u2013505 (2006).","journal-title":"Nat. Biotechnol."},{"key":"512_CR26","unstructured":"Eschelbach, J. Registration Enabling Campaign for Accelerated Development: a PPQ strategy with early investment to enable acceleration for a promising monoclonal antibody. https:\/\/cdn.ymaws.com\/www.casss.org\/resource\/resmgr\/cmc_euro\/CMC_Europe_2017_Program_v1.pdf (2017)."},{"key":"512_CR27","doi-asserted-by":"publisher","first-page":"282","DOI":"10.5731\/pdajpst.2015.006395","volume":"70","author":"M Boyer","year":"2016","unstructured":"Boyer, M., Gampfer, J., Zamamiri, A. & Payne, R. PDA J. Pharm. Sci. Technol. 70, 282\u2013292 (2016).","journal-title":"PDA J. Pharm. Sci. Technol."}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41587-020-0512-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41587-020-0512-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41587-020-0512-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:16:11Z","timestamp":1684620971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41587-020-0512-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,21]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["512"],"URL":"https:\/\/doi.org\/10.1038\/s41587-020-0512-5","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,21]]},"assertion":[{"value":"21 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author is employed by Vir Biotechnology, which is developing monoclonal antibodies for the treatment of pandemic diseases, such as COVID-19 and influenza.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}